{"schema_version":"1","generated_at":"2026-10-31T01:28:30.166Z","data_as_of":null,"url":"https://www.findmykol.com/kol/debasish-tripathy","json_url":"https://www.findmykol.com/kol/debasish-tripathy/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"debasish-tripathy","name":"Debasish Tripathy","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1194794602","orcid":"0000-0002-5711-2404","openalex":"A5110492375"},"summary":"Debasish Tripathy is an Oncology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 139 publications with 6,032 citations (h-index 27); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":139,"cited_by_count":6032,"h_index":27,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05868226","title":"PRE-I-SPY Phase I/Ib Oncology Platform Program","phase":"PHASE1","status":"RECRUITING","role":"Site investigator","sponsor":"QuantumLeap Healthcare Collaborative","source_url":"https://clinicaltrials.gov/study/NCT05868226","trial_url":"https://www.findmykol.com/trial/NCT05868226"},{"nct":"NCT03774472","title":"Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer","phase":"PHASE1/PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT03774472","trial_url":"https://www.findmykol.com/trial/NCT03774472"},{"nct":"NCT01333137","title":"A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin","phase":"PHASE1","status":"TERMINATED","role":"Overall official","sponsor":"Piramal Enterprises Limited","source_url":"https://clinicaltrials.gov/study/NCT01333137","trial_url":"https://www.findmykol.com/trial/NCT01333137"}],"source":"trials"},"payments":{"company_count":13,"program_years":{"first":2021,"last":null},"rows_total":26,"shown":3,"withheld":23,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":33.21,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194794602"},{"payer":"JAZZ PHARMACEUTICALS INC.","program_year":2024,"amount_usd":2254.18,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194794602"},{"payer":"BeiGene USA, Inc.","program_year":2024,"amount_usd":2250,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1194794602"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1194794602","source":"payments"},"publications":{"total":49,"shown":5,"withheld":44,"matched_by":"OpenAlex author record","recent":[{"title":"Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4/6 inhibition in patients with HR+/HER2- metastatic breast cancer","year":2025,"journal":"Molecular Cancer","source_url":"https://doi.org/10.1186/s12943-025-02226-9","status":"verified"},{"title":"LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells","year":2024,"journal":"Nature Cancer","source_url":"https://doi.org/10.1038/s43018-023-00695-9","status":"verified"},{"title":"Premastectomy Radiotherapy and Immediate Breast Reconstruction","year":2024,"journal":"JAMA Network Open","source_url":"https://doi.org/10.1001/jamanetworkopen.2024.5217","status":"verified"},{"title":"Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics","year":2024,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers16030492","status":"verified"},{"title":"Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into “ARness”","year":2024,"journal":"Cell Reports Medicine","source_url":"https://doi.org/10.1016/j.xcrm.2024.101595","status":"verified"}],"source":"works"},"contact":{"address_1":"1515 HOLCOMBE BLVD","city":"Houston","state":"TX","zip":"770304009","phone":"713-792-6161","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1194794602","source":"identity"},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":23,"publications":44}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2016-05-06","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}